SCHEMBL17481368

SCHEMBL17481368

Cc1cc(Nc2nc(C)ccc2[N+](=O)[O-])on1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.40
▸ CTSH P09668 1/20 0.40
▸ IDO1 P14902 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ EDNRA P25101 1/20 0.38
▸ BRD4 O60885 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ POLB P06746 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16062179 0.86 FGFR4 (0.41) ALDH1A1EDNRABRD4RAB9AMAPK1
SCHEMBL17586643 0.78 KMT2A (0.47) IDO1MAPK1KMT2AL3MBTL1LMNA
SCHEMBL29532283 0.75 ALDH1A1 (0.43) CTSBCTSHIDO1ALDH1A1MAPK1
SCHEMBL17481366 0.75 EDNRA (0.42) ALDH1A1EDNRALMNASMN1; SMN2POLB
SCHEMBL10810171 0.74 GSK3B (0.58) CTSBCTSHIDO1ALDH1A1MAPK1
SCHEMBL20202988 0.73 PKM (0.48) IDO1ALDH1A1EDNRARAB9AMAPK1
SCHEMBL17582873 0.73 AKR1B1 (0.50) ALDH1A1MAPK1KMT2AMEN1MAPT
SCHEMBL31330033 0.72 CTSB (0.47) CTSBCTSHALDH1A1KMT2ALMNA
SCHEMBL16059556 0.72 CTSB (0.40) CTSBCTSHIDO1ALDH1A1RAB9A
SCHEMBL16900176 0.72 RAB9A (0.55) ALDH1A1RAB9ANPC1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170240547-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS CHANNEL BIOSCIENCES, LLC 2017-08-24 — — US disclosed
US-9650376-B2 Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators KNOPP BIOSCIENCES LLC (US) 2017-05-16 — — US disclosed
US-20160031875-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS CHANNEL BIOSCIENCES, LLC 2016-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031875-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS KCNA7, KCNA2, KCNK17 CTSB 4057/4885CTSH 3775/4885IDO1 884/4885
US-20170240547-A1 IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS KCNA7, KCNA2, KCNK17 CTSB 4057/4885CTSH 3775/4885IDO1 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback